BOSTON LIFE SCIENCES INC /DE
8-K, EX-10.2, 2000-06-09
PHARMACEUTICAL PREPARATIONS
Previous: BOSTON LIFE SCIENCES INC /DE, 8-K, EX-10.1, 2000-06-09
Next: BOSTON LIFE SCIENCES INC /DE, 8-K, EX-10.3, 2000-06-09



<PAGE>

                                                                    Exhibit 10.2

                                 Schedule 4.3


I.  Authorized Capital

        A. Common Stock         30 million

        B. Preferred stock      1 million, of which approximately 15,000 have
                                been designated as Series A and of which 475,000
                                have been designated as Series C Convertible
                                Preferred Stock

II.  Outstanding Capital                       Equivalent Shares of Common Stock
                                               ---------------------------------

        A. Common Stock         approximately             19,000,000

        B. Stock Options        approximately              2,100,000

        C. Warrants             approximately              4,600,000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission